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ABSTRACT
Eukaryotic transcription activation domains (ADs)
are not well defined on the proteome scale. We sys-
tematicallly tested  6000 yeast proteins for trans-
criptional activity using a yeast one-hybrid system
and identified 451 transcriptional activators. We
then determined their transcription activation
strength using fusions to the Gal4 DNA-binding
domain and a His3 reporter gene which contained a
promoter with a Gal4-binding site. Among the 132
strongest activators 32 are known transcription
factors while another 35 have no known function.
Although zinc fingers, helix–loop–helix domains
and several other domains are highly overrepresen-
ted among the activators, only few contain character-
ized ADs. We also found some striking correlations:
the stronger the activation activity, the more acidic,
glutamine-rich, proline-rich or asparagine-rich the
activators were. About 29% of the activators have
been found previously to specifically interact with
the transcription machinery, while 10% are known
to be components of transcription regulatory com-
plexes. Based on their transcriptional activity,
localization and interaction patterns, at least six
previously uncharacterized proteins are suggested
to be bona fide transcriptional regulators (namely
YFL049W, YJR070C, YDR520C, YGL066W/Sgf73,
YKR064W and YCR082W/Ahc2).
INTRODUCTION
Transcriptional regulators (TRs) that activate transcription are
usually composed of a DNA-binding domain (DBD) and an
activation domain (AD). The DBD targets these proteins to
a speciﬁc binding site in the promoter or enhancer region of a
gene and the AD mediates transcription initiation (1).
Transcriptionalactivators inyeast were among the ﬁrst tobe
studied in detail. In all known cases they recruit additional
proteins or whole complexes to the pertinent promoters, even-
tually leading to the binding of one of the three RNA poly-
merases. For example, the yeast transcription regulator Gal4
is involved in regulation of galactose metabolism and acti-
vates transcription by recruitment of the basal transcription
machinery (2–5).
The Gal4–AD can recruit Tra1, a component of the SAGA
complex, to the upstream activating sequence (UAS), where
Gal4 itself is bound. SAGA, in turn, recruits the mediator
complex to the UAS. The Gal4–AD can also directly recruit
the mediator complex. In any case, the UAS bound mediator is
required for recruitment of general transcription factors to the
core promoter and assembly of the pre-initiation complex.
While DBDs are extremely well characterized both func-
tionally and structurally, ADs do not share easily recognizable
motifs or structures (6). Accordingly, no speciﬁc pattern or
motif for the identiﬁcation of an AD has been deﬁned in pat-
tern/domain databases such as Prosite (7) or SMART (8). In
contrast, >50 patterns for DBDs have been documented in the
SMART database.
Because the activation properties of transcriptional activat-
ors cannot easily be recognized by sequence homology,
several studies tried to identify more general sequence features
resulting in a number of different AD classes (9), e.g. acidic
activators (10), glutamine-rich activators (11) and proline-rich
activators (12). In addition, a few rather unspeciﬁc properties
like hydrophobic patches interspersed with hydrophilic
residues (13) or amphipatic alpha helices (14) have been iden-
tiﬁed. These analyses culminated in the ﬁnding that even small
chemical compounds with a certain pattern of hydrophobic
and hydrophilic residues are sufﬁcient for transcriptional
activation (15).
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interaction partners of transcriptional activators, including
TATA-box binding protein, TFIIB, TFIIH (4,16–20) and
several others [reviewed in (21)].
Although previous studies have attempted to screen for
transcriptional activators [e.g. (22)], we do not know of
such a systematic screen in yeast. Incidentally, we approached
the problem indirectly by doing systematic yeast-two-hybrid
(Y2H) screens (23) which are based on a split transcription
regulator, e.g. Gal4. In these screens all yeast open reading
frames (ORFs) have been fused to the DBD of yeast Gal4 and
tested for interaction with every other yeast protein. Unfortu-
nately, in many cases no interactions could be detected
because the Gal4–DBD fusion protein was activating tran-
scription without requiring a second fusion protein, that is,
the Gal4–AD fusion, also known as prey.
Gal4–DBD fusion proteins that activate transcription of a
reporter gene without requirement of a prey protein are called
‘auto-activators’ (or activators for short) and thereby possess
properties of an AD. Our genome-wide two-hybrid screen
thus provided data about activation properties of nearly all
yeast proteins. Up to now this information has not been
used for the understanding of transcription in yeast. However,
similar assays have been used previously by Wiesner et al.
(24) and Ma and Ptashne (25) for screening human and
Escherichia coli proteins/peptides for their transcriptional
activation properties. By design such screens do not necessar-
ily identify physiological activators as the fusion partners are
artiﬁcially targeted to the promoter of a single, arbitrarily
selected reporter gene.
Bearing these caveats in mind, we not only selected Y2H
auto-activators but also measured their activation strength.
In a second step we analyzed these auto-activators for their
domain content and other sequence properties. We found that
auto-activators possess speciﬁc physicochemical properties,
like certain amino acid clusters, and can often be found in
known complexes of the transcription machinery. Many of
the activators identiﬁed in this study are known physiological
activators. However, many do not appear to be localized to
the nucleus under standard laboratory conditions and thus
may not act as bona ﬁde transcription factors.
Nevertheless, we believe that even such cases can shed
light on the mechanisms of transcriptional activation
similar to heterologous proteins such as VP16 which helped
to uncover many mechanistic details of transcriptional
activation.
MATERIALS AND METHODS
Selection of transcriptional activators
Transcriptional activators were identiﬁed in two genome-wide
Y2H studies ofyeast proteins (26,27).The‘Ito screen’ resulted
in 392 auto-activators which were identiﬁed by testing essen-
tially all yeast proteins for transcription activation when fused
to the DBD of Gal4 as full-length ORFs (27). The ‘Uetz set’
contains 68 auto-activators and was identiﬁed in two-hybrid
screens of  600 yeast proteins (26).
For analysis of transcription activator properties activators
identiﬁed by Ito et al. were selected from the Uetz bait library
(26) and combined with the Uetz activators to form a set of
451 proteins. These two independent selection steps ensured
correct identiﬁcation of activators. For further quality
control, we sequenced 48 samples from the Ito collection
and checked another 29 from the Uetz lab by colony PCR
for correct insert size. Among these 77 clones only 1 (out
of the 29 mentioned) did not match the expected identity
and was thus excluded from further analysis. The activators
of the ‘Ito set’ were then divided into activation strength
groups (see below). However, 79 strains did not grow well
enough to be quantiﬁed, although they were reported to be
activators. Their activation strength has been annotated as
‘not available’ (NA) in Supplementary Table 1.
Yeast strains
The activators were selected from the bait proteins described
by Uetz et al. (26) and Hazbun et al. (28), and consisted
of full-length ORFs fused to the Gal4–DBD in the CEN4
plasmid pOBD2 (29). These DBD-activator gene constructs
were expressed in the strain YULH (MATa, ura3-52, trp1,
lys2, his3, leu2, gal4D, gal80D, GAL1-URA3, GAL1-lacZ).
This ‘activator strain’ was re-arrayed onto 96-well plates
and mated with yeast cells ofthe opposite mating type [namely
PJ69-4a:MATa,trp1-901,leu2–3,ura3–52,his3–200,gal4D,
gal80D, GAL2-ADE2, LYS::GAL1-HIS3, met2::GAL7-
lacZ (26,30)] carrying an empty prey vector pLP-GADT7
(Clontech). This mating was necessary in order to introduce
the HIS3 reporter gene of the PJ69-4 a strain.
The handling of yeast colonies was done by automated
robotic procedures employing a Biomek 2000 robotic work-
station (Beckman Coulter).
Measurements of transcriptional activation strength
The activation strength was measured by two different assays
which measure the expression of two reporter genes: His3,
which encodes imidazoleglycerol-phosphate dehydratase
and catalyzes the sixth step in histidine biosynthesis (LTH
assay) and beta-galactosidase (bGal assay).
His3 gene expression was measured (LTH assay) by grow-
ing yeast cells on selective media lacking leucine (L), trypto-
phane (T) and histidine (H) with the former two corresponding
to markers on the two vectors pOBD2 and pLP-GADT7.
Activity of the HIS3 reporter was quantiﬁed by increasing
amounts of 3-aminotriazole (3-AT), a competitive inhibitor
of His3. The lowest concentration of 3-AT that inhibited
growth was considered as the activation strength of the
gene construct (29). This assay was done in quadruplicate
in order to ensure reproducibility (for detailed results see
Supplementary Table 1).
The bGal assay was performed in 96-well plates using
ONPG as a substrate (31). Brieﬂy, diploid yeast cells were
grown overnight at 30 C in 100 ml selective media (leucine
and tryptophane deﬁcient), the media was replaced by 50 ml
Z-buffer [1.6% (w/v) Na2HPO4, 0.55% (w/v) NaH2PO4,
0.075% (w/v) KCl and 0.025% (w/v) MgSO4, pH 7] and
the cells lysed by two freeze-thaw cycles. For normalization
of the cell density OD600 was measured using a microplate
reader (Elx808, Bio-Tek Instruments, VT). The assay was
started by adding 50 ml of 1.5 mg/ml ONPG in Z-buffer
and the initial OD405i wasmeasured immediately.The reaction
was incubated at 37 C and OD405 measured at different time
956 Nucleic Acids Research, 2006, Vol. 34, No. 3points. Time points still in the linear range were considered
for calculation of the activation strength.
bGal activity ¼
OD405ðtÞ   OD405i
OD600 · tðminÞ
:
Finally, the mean bGal activity of a randomly chosen set of
genes not found to possess auto-activation properties was sub-
tracted. This assay was done in triplicates and mean and SEM
were calculated for each activator (Supplementary Table 1).
Data sources and analysis
General yeast protein properties, e.g. molecular mass and
pI, protein annotations and gene ontology (GO) classiﬁcation
were downloaded from SGD (32) as of June 2005. Protein
localizationdatawerefromHuhetal.(33),whichwasassumed
to be less biased compared with curated data (e.g. GO com-
ponent data). The abundance of proteins was compared using
the genome-wide measurements by Ghaemmaghami et al.
(34). Protein interaction data were downloaded from the
MIPS database (35).
Overrepresentation of certain GO terms was assessed using
the program FuncAssociate (36). For in detail analysis of
known TR function and deﬁnition of the set of known TRs
the GO slim term ‘transcription regulator activity (F-GO
30528)’ was used. Table 1 summarizes the protein sets that
were used for analysis. Proteins annotated with the F-GO term
‘Transcriptional activator activity’ (TermID 16563) from the
YPD database (Biobase, Germany) served as an additional
reference set (37).
Physicochemical properties
General physicochemical properties, e.g. molecular mass
and isoelectric point, were taken directly from the datasets
of the SGD (32). Calculation of amino acid groups and
segments/clusters with speciﬁc physicochemical properties,
e.g. charge, were done employing the SAPS program (38).
Frequencies of amino acids were directly calculated from
SGD sequence data. The minimal and maximal pI of a protein
was calculated as the lowest and highest pI of a 20 amino acid
window, respectively. Amino acid clusters in a protein were
deﬁned as the maximal count of a speciﬁc amino acid in a
20 amino acid window of the protein. GRAVY (grand average
of Hydropathicity) values were calculated as the sum of
hydropathy values for all of the amino acids, divided by the
number of residues in the sequence (39). Aromaticity is the
relative frequency of aromatic amino acids (39) and the codon
adaptation index (CAI) is an empirical measure of synonym-
ous codon usage bias, which is positively correlated with
the expression level of genes (40) (see also ‘http://www.
yeastgenome.org/help/protein_page.html’).
Protein domains
The occurrence of protein domains in the set of Y2H activators
was assessed using the SMART domain database (8). The
number of proteins with each domain in the Y2H activator
set and the whole genome was counted and the enrichment
in the former set was calculated. Signiﬁcance was tested
using Fisher’s exact test and Holm’s procedure for multiple
testing correction (41).
Protein interactions
A protein–protein interaction map of transcription activators
was generated using Cytoscape (42). In the Cytoscape map
only physical binary protein interactions from the MIPS data-
base were considered. Only activators and their direct inter-
action partners, bridging at least two activators, were selected.
The percentage of activators that interacted with other
transcription factors (i.e. proteins with the GO slim term ‘tran-
scription [P-GO 6350])’ was calculated using the set of
physical binary protein interactions from the MIPS database.
Similarly, we counted with how many transcription com-
plexes our activators interacted. A ‘transcription complex’
was deﬁned as a protein complex with at least 50% of the
proteins annotated as being involved in transcription. The
protein interactions with these complexes were assessed by
using the MIPS data of protein complexes ﬁltered to contain
only high-throughput data (for reduction of bias of well-
characterized proteins).
Ranking of interaction partners was done by counting
with how many proteins of a speciﬁc protein set a given
yeast protein interacted (using high-throughput protein com-
plex data from the MIPS database).
Statistical analysis
Data processing was done with PERL (www.perl.org) and
statistical calculations with R (43). Correction for multiple
testing was done with Holm’s procedure using the multtest
package of R (41,44).
RESULTS
Y2H activators and their activation strength
About 450 Y2H activators were identiﬁed previously in two
genome-wide Y2H screens (Supplementary Table 1) (26,27).
However, these proteins were not listed in the original pub-
lication nor did these studies provide any quantitative data for
the activation strength. Therefore, we measured the activation
strength of the activators using two different reporter genes
whose expression depends on their level of transcription: His3
and b-galactosidase (bGal assay) (Figure 1, see also Materials
and Methods and Supplementary Table 1). According to the
activation strength in the LTH assay the activators were
grouped into weak (3–25 mM 3-AT), medium (50–200 mM
3-AT) and strong (>200 mM 3-AT) activators. These groups
Table 1. Protein sets
Protein set Description
All yeast All yeast proteins
Non acts All yeast proteins not in the activator list
TR Known transcriptional activators/regulators
(GO slim term ‘transcription activator activity’)
All acts All Y2H activators
Nucleus Nuclear proteins [Huh et al. (33)]
Acts nucleus Y2H activators localized to the nucleus
LTHw, LTHm, LTHs Weak (LTHw), medium (LTHm), and
strong (LTHs) activators in LTH assay
TR+1, nucleus+1,
acts nucleus+1
Protein sets as indicated above but including
directly interacting proteins in the analysis of
binary protein interactions.
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assay distribution was divided into strong activators (bGals)
which activate above the median and weak activators that
activate below the median (bGalW).
A comparison of activation strength in both assays
revealed an intermediate (Pearson’s correlation coefﬁcient
of 0.58) but highly signiﬁcant correlation (P < 2.2e 16) of
activation values (Figure 1B). Although both reporters are
driven by the Gal1 promoter, the lacZ reporter is actually
present in two copies with two different promoters (a GAL7
promoter in PJ69-4a and a GAL1 promoter in YULH). We
have not tried to determine the contribution of each of the
two lacZ genes and restricted the following analysis to the
His3 data.
In summary, a total of 72 weak, 179 medium and 75 strong
transcriptional activators were identiﬁed in these experiments
(Table 2 and Supplementary Table 1).
Function
First, we wondered if Y2H activators also act in vivo as tran-
scriptional activators. Surprisingly, only 92 (or 20%) of the
451 activators had the GO attribute ‘transcription regulator
activity’ (GO 0030528). Transcription activity was signiﬁc-
antly correlated with activation strength: 27% of all strong
activators are annotated as having ‘transcription regulatory
activity’ (Figure 2A) whereas this annotation drops to 21
and 7% of the medium and weak activators, respectively.
These numbers are signiﬁcantly higher than for the Y2H
non-activators ( 3%). As an additional reference set we
selected 138 proteins annotated to possess ‘transcriptional
activator activity’ in the YPD database. Only 55 (or 12%)
of the Y2H activators were annotated as transcriptional activ-
ators in YPD. This annotation correlated with the activational
strength: 19% of strong, 16% of medium and 4% of weak
activators were annotated with this term (Supplementary
Table 1). This suggests that many more proteins may act as
transcriptional activators than currently known.
Localization
Transcription takes place in the nucleus. We wondered if
Y2Hactivatorswerealsolocalizedinthenucleus andanalyzed
their localization using the large-scale localization study by
Huh et al. (33). While 22% of the Y2H non-activators were
localized to the nucleus, 41% of the activators were nuclear
(Figure 2B). The activation strength was also correlated with
nuclear localization:e.g. the percentage of nuclear localization
grew from 35% for weak activators to almost 50% in strong
activators. However, the percentage of strong activators in
the nucleus was still lower than the value of 67% found for
known transcriptional activators (GO annotation ‘transcription
regulator activity’).
Correlating GO function and localization revealed a sig-
niﬁcant overrepresentation of known TRs among nuclear
activators and among nuclear-cytoplasmic proteins, but not
in the set of exclusively cytoplasmic proteins (Supplementary
Figure 1). Strikingly, 47% of nuclear Y2H activators are
known TRs. This number indicates that a large fraction of
these activators may act as transcription factors in vivo
although this activity has not been recognized previously.
As a large fraction of activator proteins have no assigned func-
tion ( 35%) this ﬁnding can contribute to the functional
annotation of these proteins (see below) (Table 3).
Abundance
It has been known for a long time that transcriptional activ-
ators are often expressed at low levels. This notion is also
reﬂected in the lower concentration of known transcription
regulators (Figure 2C). With an average copy number of
 4000 proteins per cell the Y2H activators conﬁrmed this
ﬁnding and even showed a trend towards lower abundance
the stronger the activation was (Figure 2C). However, this
trend was not signiﬁcant.
General physicochemical properties of Y2H activators
Although characteristics such as abundance and localization
allow us to classify activators, they do not explain their
behavior. In fact, it has been unclear which properties turn
a protein into a transcriptional activator even though certain
Figure 1. Activation strength in Y2H activators. (A) Number of activators
showing the indicated activation strength in the LTH assay. They were
divided into weak (LTHw), medium (LTHm) and strong (LTHs)
activators as indicated. (B) Correlation of activation strength in LTH and bGal
assays. The actually measured values are shown as dots, the median and two
quartiles by an overlayed boxplot. Dotted lines indicate the median of bGal
activity and LTH activity, respectively. For an explanation of datasets see
Table 1.
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Gal4–DBD and expressed in yeast strain with Gal4-binding sites in the
His3 reporter gene
Name ORF Process/function Loc.
ACE2 YLR131C Transcription N
ACF2 YLR144C Cytoskeleton S
ADR1 YDR216W Transcription N
AOS1 YPR180W Protein modification N
APC4 YDR118W Protein catabolism N
APL2 YKL135C Vesicular transport C
ASM4 YDL088C Nuclear organization N,ER
ATC1 YDR184C Response to stress# N
BCK2 YER167W Cell cycle# C,N
BFR2 YDR299W Vesicular transport# N
CAK1 YFL029C Meiosis,cell cycle C
CHA4 YLR098C Transcription N
CRZ1 YNL027W Transcription C,N
CSE2 YNR010W Transcription N
CUP2 YGL166W Transcription N
ECM22 YLR228C Transcription N
FCP1 YMR277W Transcription N
GAC1 YOR178C Meiosis
GAL11 YOL051W Transcription N
GLN3 YER040W Transcription N
GYP1 YOR070C Vesicular transport G
HAP4 YKL109W Transcription N
HSF1 YGL073W Transcription N
IDS2 YJL146W Meiosis# C,N
IKI1 YHR187W Transcription N
IME1 YJR094C Transcription N
ISF1 YMR081C Cellular respiration# ?
LTV1 YKL143W Unknown# C
MAS6 YNR017W Transport M
MBR1 YKL093W Cellular respiration# ?
MCD4 YKL165C Protein modification# S
MED4 YOR174W Transcription N
MED8 YBR193C Transcription N
MET4 YNL103W Transcription N
MRS6 YOR370C Transport C
MSB4 YOL112W Cytoskeleton S
MSN2 YMR037C Response to stress N
MVP1 YMR004W Transport# C
NAM7 YMR080C RNA metabolism C
NAP1 YKR048C Budding C,N
NCA3 YJL116C Organelle organization# ?
NUP100 YKL068W Nuclear organization N,ER
PAT1 YCR077C Cell cycle# C
PCL6 YER059W Carbohydrate metabolism
PDC2 YDR081C Transcription N
PEX19 YDL065C Organelle organization# C
PFK27 YOL136C Carbohydrate metabolism C
PHO4 YFR034C Transcription C,N
PPG1 YNR032W Protein modification C,N
PUP2 YGR253C Response to stress N,ER
PUT3 YKL015W Transcription N
REC114 YMR133W DNA metabolism# N
RIM15 YFL033C Response to stress C
RLM1 YPL089C Cell wall N
ROX3 YBL093C Transcription N
RPA12 YJR063W Transcription N
RPB3 YIL021W Transcription N
RPI1 YIL119C Signal transduction N
RPP1A YDL081C Protein biosynthesis C
RSP5 YER125W Nuclear organization N
RTG1 YOL067C Transcription C,N
SCD5 YOR329C Vesicular transport V
SCH9 YHR205W Protein modification C
SIN4 YNL236W Transcription N
SIW14 YNL032W Response to stress C
SLA1 YBL007C Cell wall S
SNF2 YOR290C Transcription N
SPT21 YMR179W Transcription# N
Table 2. Continued
Name ORF Process/function Loc.
SSN2 YDR443C Transcription N
STE5 YDR103W Signal transduction V,C,N
SWI3 YJL176C Transcription N
SWI5 YDR146C Transcription C,N
TOA1 YOR194C Transcription N
UBP3 YER151C Protein modification C
YAL014C YAL014C Transport C
YAP1802 YGR241C Vesicular transport S
YBL081W YBL081W Unknown# ?
YBR061C YBR061C Protein biosynthesis C
YBR271W YBR271W Unknown C
YCR082W YCR082W Unknown# C,N
YDL161w YDL161W Vesicular transport S
YDR031w YDR031W Unknown# C,N
YDR213W YDR213W Transcription C,N
YDR223W YDR223W Unknown# ?
YDR260C YDR260C Cell cycle# N
YDR291W YDR291W Unknown N
YDR320C YDR320C Organelle organization# ER
YDR330W YDR330W Protein catabolism# C,N
YDR489W YDR489W DNA metabolism N
YDR520C YDR520C Unknown# C,N
YER045c YER045C Transcription N
YER051W YER051W Unknown# ?
YGL036W YGL036W Unknown# C
YGL079W YGL079W Unknown# C
YGL223C YGL223C Vesicular transport# G
YGR120C YGR120C Vesicular transport G
YGR130C YGR130C Unknown# C
YHL012W YHL012W Unknown# ?
YHR160C YHR160C Transport P
YIL019W YIL019W Unknown# C,N
YIL079C YIL079C Transport# N
YJL029C YJL029C Vesicular transport# G,C
YJL181W YJL181W Unknown# ?
YJR070C YJR070C Unknown C,N
YJR119C YJR119C Unknown# C,N
YKL059C YKL059C RNA metabolism# N
YKL171W YKL171W Protein catabolism C
YKR060W YKR060W Ribosome biogenesis N
YKR064W YKR064W Unknown# C,N
YKR077W YKR077W Unknown# C,N
YLL013C YLL013C RNA metabolism C
YLR135W YLR135W DNA metabolism N
YLR192C YLR192C Protein biosynthesis C
YLR285W YLR285W Vitamin metabolism C
YLR445W YLR445W Unknown# ?
YML037C YML037C Unknown# V
YMR030W YMR030W Cellular respiration# M,N
YMR048W YMR048W Cell cycle# N
YMR181C YMR181C Unknown# ?
YMR195W YMR195W Unknown# V
YMR295C YMR295C Unknown# S
YMR299C YMR299C Unknown# C
YNR069C YNR069C Unknown# ?
YOR066W YOR066W Unknown# ?
YOR166C YOR166C Unknown# ?
YOR262W YOR262W Unknown# C
YPL105C YPL105C Unknown# C
YPL229W YPL229W Unknown# C
YPL233W YPL233W Cell cycle# N
YPL250C YPL250C Unknown# ?
YPR008W YPR008W Transcription N
YPR179C YPR179C Transcription N
unknown (?).
3AT concentrations of 200 mM or more are required to suppress the amount of
His3 expressed in these strains. Process/function abbreviated after GO annota-
tioninSGD,# ¼ molecularfunctionunknown.Localization(Loc.)encodedas
nuclear(N),cytoplasmic(C),cytoskeletal/cellwall(S),Golgi(G),endoplasmic
reticulum(ER),peroxisome(P),vesicle/membranes(V),mitochondrion(M)or
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been identiﬁed (10). We therefore revisited the inﬂuence of
physicochemical properties on the propensity of a protein to
activate transcription.
Well-deﬁned general properties were analyzed ﬁrst
and included the isoelectric point (Figure 3A), molecular
mass (Figure 3B), overall hydrophobicity (GRAVY score)
(Figure 3C) and aromaticity (Figure 3D). The most pro-
nounced effect was found for the isoelectic point: the mean
pIforactivatorswasfoundtobe 1.5pHunitsbelowthevalue
for non-activators. This effect was also observed for activators
in the nucleus, although with  0.5 pH units the difference
between nuclear localized activators and nuclear proteins in
general was lower. Interestingly, known TRs had only a
slightly reduced mean pI, which was even higher than for
nuclear proteins in general. However, proteins annotated
as ‘TRs’ may include non-activating regulators too. The inﬂu-
ence of activation strength onto the mean pI was not signiﬁ-
cant (judged by Student’s t-test).
The mean molecular weight of activators was found to be
 9 kDa higher than for non-activators. This tendency is
also reﬂected by the higher mean molecular weight of
known TRs. Activators in the nucleus were not signiﬁcantly
larger than nuclear proteins in general but we found that the
mean molecular weight increased with activation strength
(Figure 3B).
The overall hydrophobicity (GRAVY score) and the
aromaticity showed a similar pattern. Both properties were
reduced in activators as well as in known TRs. The effect
was much smaller for the GRAVY score but highly signiﬁcant
for nuclear localized proteins and activators (Students’t
t-test P ¼ 2.4e 5).
In addition, the CAI was analyzed (Figure 3E). As lower
codon scores are associated with lower protein expression
levels (34), the lower CAI for activators as well as for
known TRs supports the previous ﬁnding of lower protein
levels for these two protein sets (Figure 2C).
As expected, known TRs generally showed similar
properties as the Y2H activators except for the isoelectric
point.
Amino acid clusters
It has been known for a long time that certain amino acids
are overrepresented in transcriptional activators, in particular
acidic and basic residues and certain other amino acids such as
glutamine. We wondered if this is true for our activator set as
well. As basic amino acid clusters are also acting as nuclear
localization signals, we only took activators into account that
are known to be localized to the nucleus and compared them
with the remaining nuclear proteins. After correction for
multiple testing using Holm’s procedure (41) 15 parameters
involving certain amino acids remained highly signiﬁcant
(Supplementary Table 2). These included the minimum pI
in a 20 amino acid window, the overall percentage of several
amino acids (Ala, Gly, Ser, Val, Lys, Asn, Gln) and amino
acid clusters (Ser, Asp, Pro, Asn, Gln) and, in addition, the
amino acids Lys and Arg and the net charge (amino
acids [Lys + Arg]   [Glu + Asp] ¼ KR   ED). A detailed
analysis of the amino acid clusters and the minimum pI is
shown in Figure 4. A detailed analysis of the remaining
properties is shown in Supplementary Figure 2.
Taken together, the analysis of physicochemical properties
showed that Y2H activators tend to possess a lower isoelectric
point, have a lower hydrophobicity, higher molecular weight,
Figure 2. Function, localization and abundance of yeast activators. (A)
Percentage of proteins annotated to have ‘TR activity’ (GO term, see also
Supplementary Table 1). (B) Percentage of protein localized to the nucleus
as analyzed by Huh et al. (33). (C) Abundance of proteins as analyzed by
Ghaemmaghami et al. (34).
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asparagine clusters.
Protein domains
Transcriptional ADs are still not well deﬁned structurally.
This is also reﬂected in specialized domain databases such
as SMART (8) or Interpro (45) which have hardly any deﬁned
entries for transcriptional ADs. Therefore we have analyzed
the Y2H activators for enrichment of known domains. Not
unexpectedly, certain DBDs such as helix–loop–helix motifs
or zinc ﬁngers are indeed signiﬁcantly overrepresented
among the activators (Supplementary Table 5).
Certain domains are also signiﬁcantly underrepresented
such as the AAA domain. However, these domains are not
further considered here.
Binary protein–protein interactions
Speciﬁc transcription activation is mediated by physical
contact with the transcriptional machinery or other factors
necessary for transcription, like chromatin remodeling pro-
teins (4,5,16,18–20).
Activators form a tightly connected protein interaction net-
work (Figure 5A). Therefore, we wondered if the Y2H activ-
ators had any known interactions with the transcription
machinery or other proteins (Figure 5B).
Signiﬁcantly more nuclear Y2H activators ( 36%) interac-
ted with components of the transcription machinery compared
with all nuclear proteins ( 23%). The same is true for known
transcription regulators which show an even higher fraction of
proteins interacting with the transcription machinery ( 46%).
Taking bridging proteins into account (i.e. transcription
proteins that can be reached over two protein interaction
edges), the number of proteins interacting with transcription
factors even increases to  57% (nuclear Y2H activators) and
 64% (transcription regulators), respectively. All mentioned
differences are highly signiﬁcant judged by Fisher’s exact test
(P < 0.01). Remarkably, activation strength showed no effect
on the number of proteins interacting with the transcription
machinery.
Protein complexes
Because transcription is carried out by several large protein
complexes such as RNA polymerase, TAFs, mediator and the
like, we wondered with which of these complexes the Y2H
activators interacted. Therefore we analyzed complexes from
large scale MS studies (35,46,47) which had at least 50%
of their proteins annotated as ‘transcription’-related for the
presence of Y2H activators (Figure 5C). Of nuclear activators
19% interacted with transcription complexes compared with
8% of all nuclear proteins. An even higher fraction (27%) of
known TRs interacted with complexes involved in transcrip-
tion. Strikingly, Y2H activators in the nucleus that were not
annotated as TRs showed a signiﬁcant higher number of
interactions with the transcription machinery compared with
other nuclear non-TR proteins. This might indicate that many
of these proteins are also bona ﬁde TRs (see below). All these
differences are highly signiﬁcant judged by Fisher’s exact test
(P < 0.01).
To reveal the nature of proteins interacting with trans-
criptional activators we compiled the most frequent interactors
of our Y2H activators. The top 15 interacting proteins of dif-
ferent protein query sets are given in Supplementary Table 4.
This analysis reveals that a high percentage of activators, as
well as known TRs interact with components required for
transcription. These were components of the RNA-
polymerase II holoenzyme and proteins involved in chromo-
someremodeling,likethe SAGAcomplex.Nuclearproteinsin
general do not show this tendency with only one interactor
(YDL014W) shared between Y2H activators and nuclear pro-
teins in general (Supplementary Table 4). Interestingly, both
nuclear activators and transcription regulators interacted with
the metabolic enzyme alcohol dehydrogenase. With 21 and
19%, respectively, the fractions were much higher than in
the set of nuclear proteins ( 10%, not shown).
In summary, Y2H activators as well as known TRs tend to
speciﬁcally interact with components of the transcription
machinery even though such interactions have not been
shown for the majority of either group.
Y2H activators as bona fide transcriptional regulators
Many of the Y2H activators described here may be bona
ﬁde TRs even if they have not been annotated as such. We
therefore may have identiﬁed Y2H activators of yet unknown
function given their ability to efﬁciently activate transcrip-
tion, their nuclear localization and their protein interaction
pattern with other components of the transcription machinery.
The following Y2H activators of yet unknown function are
predicted to be physiological activators.
YFL049W, a protein with no assigned function, was
co-puriﬁed with Rtt102p, Snf2p and Snf5p indicating that it
is a real Swi/Snf component (48). The yeast SWI/SNF com-
plex is required for transcription of several yeast genes and
has been shown to alter nucleosome structure in an ATP-
dependent reaction. Transcription stimulation by SWI/SNF
requires an AD with which it directly interacts. Strikingly,
the acidic ADs of VP16, Gcn4, Swi5 and Hap4 interacted
Table 3. List of Y2H activators of unknown function predicted to be TRs
ORF Name Activation strength
(in mM 3AT)
Biological
process (GO)
Localization Interaction
with transcription
machinery
Additional
evidence
YFL049W YFL049W 100 Unknown Nucleus Yes Yes
YJR070C YJR070C 200 Unknown Cytoplasm, Nucleus No Yes
YDR520C YDR520C >200 Unknown Cytoplasm, Nucleus Yes Yes
YGL066W SGF73 50 Protein modification Nucleus Yes No
YKR064W YKR064W 200 Unknown Cytoplasm, Nucleus No Yes
YCR082W YCR082W 200 Unknown Cytoplasm, Nucleus Yes No
Nucleic Acids Research, 2006, Vol. 34, No. 3 961directly with the puriﬁed SWI/SNF complex and with the
SWI/SNF complex in whole-cell extracts (16). A physical
interaction of YFL049W with the SWI/SNF complex together
with the strong transcription activation properties (strong
Y2H activator) strongly supports the possible transcription
stimulation function involving the SWI/SNF complex.
YJR070C is both localized to the nucleus and the cyto-
plasm. Nucleic acid binding proteins are overrepresented in
its set of genetic and physical interaction partners. As it is
known to bind eIF5 (49) it might have regulatory functions
involving translation in the cytoplasm and transcription in
the nucleus.
Figure3.Generalphysicochemicalpropertiesofactivators.MeanandSEMofphysicochemicalpropertiesisshownforseveralproteinsets.(A)Isoelectricpoint(pI),
(B) molecular mass (Mr), (C) GRAVY score (overall hydrophobicity), (D) aromaticity and (E) Codon adaptation index (CAI). For details see text.
962 Nucleic Acids Research, 2006, Vol. 34, No. 3YDR520C, also localized to the cytoplasm and the nucleus,
was shown to bind a zinc ﬁnger-containing transcriptional
repressor, Dal80 (27), suggesting the interesting hypothesis
that Dal80 is repressing the activator properties of YDR520C.
YGL066W/SGF73, a protein with unknown molecular
function, was identiﬁed as a novel subunit of the SAGA
(Spt/Ada/Gcn5 acetylase) multisubunit complex (50).
Ataxin-7 is the human ortholog of the yeast SAGA SGF73
subunit and is a bona ﬁde subunit of the human TFTC-
like transcriptional complexes (TATA-binding protein-free
TAF-containing complex) (51). The physical association
of YGL0066W with the TFTC transcription complex and
its activation properties supports a role in transcriptional
regulation function.
Figure 4. Aminoacidclustersofactivators.(A–E)Aminoacidclustersindicatingthemaximumnumberoftherespectiveaminoacidinawindowof20aminoacids
oftheprotein(FortheremainingaminoacidclustersseeSupplementaryFigure2).(F)Minimumisoelectricpoint(pI)ina20aminoacidswindow,summarizingthe
effect of charged amino acids (glutamate, aspartate, arginine, lysine).
Nucleic Acids Research, 2006, Vol. 34, No. 3 963A proﬁles/patterns analysis of YKR064W revealed the pres-
ence of a Zn[2]-Cys[6] fungal-type binuclear cluster domain
in the N-terminal region. This domain binds to DNA and is
also found in ArgR2p, a component of the ARGR transcription
regulatory complex (ArgR1p, ArgR2p, ArgR3p, Mcm1p) (this
domain already lead to the annotation as transcription factor in
the YPD database)(52).Asearch inthe eMOTIF database (53)
reveals a ‘fungal transcriptional regulatory protein’ motif (the
eMotif search tool is also available in SGD). Together with the
strong transcriptional activation properties of YKR064W, this
ﬁnding indicates a true transcriptional regulation and activator
function of YKR064W relying on its DNA binding as well
as its AD, probably involving the ARGR transcription regu-
latory complex.
YCR082w (¼Ahc2) is a protein localized in the nucleus
as well as in the cytoplasm without known function. It was
identiﬁed as a strong activator in this study and is known
to interact with chromatin reorganization components like a
histone acetyltransferase complex (Ahc1) (26) and Abf1, a
DNA-binding protein involved in chromatin reorganization
(54). In addition, YCR082w interacts with a transcription
factor, Srb4, a subunit of the RNA polymerase II mediator
complex (27).
DISCUSSION
Transcriptional activation is the basis of the Y2H system
(26,27). However, some bait proteins activate transcription
without requiring an interacting protein that bears a separate
AD. In fact, this property prevents the study of many TRs by
means of the two-hybrid system. Nevertheless, we realized
that thisobservation can extend our knowledge about the prop-
erties of transcriptional ADs.
In the course of this study we took previously identiﬁed
(but mostly unpublished) activators from several Y2H screens
(26,27) and measured their activation strength. In addition, we
lookedfor properties distinguishingthis set from non-activator
proteins. Although many well-characterized TRs and nuclear
proteins are highly overrepresented in the set of Y2H activ-
ators, we identiﬁed many which have not been associated with
transcription previously. Irrespective of their physiological
role, these activators must be able to interact with and recruit
the transcriptional machinery.
Which features or sequences mediate the recruitment of
the general transcriptional machinery to the activator?
Although there is no single feature several rather general prop-
erties of transcription activators have been deﬁned previously.
These included the protein sequence composition as in acidic
activators (25) or more speciﬁc features such as deﬁned
interactions between activators and the basal transcription
machinery [e.g. (21)].
Acidic activators, i.e. activators with stretches of acidic
amino acids, were the ﬁrst class to be identiﬁed in yeast
Figure 5. Protein–protein interactions of transcription activators. (A) This
protein interaction network shows the activators (red) and the proteins inter-
acting with at least two activators. Proteins involved in transcription are
indicated by a diamond shape and the activation strength (bGal and LTH
combined) is reflected by the node size. Individual protein names can be
identified in the online version of this figure. (B) Protein–protein interactions
of activators and control groups with other proteins involved in transcription
(P-GO term ‘transcription’). Physical, binary protein interaction data from the
MIPS database (35) were used. The right three columns include indirect inter-
actions involving a bridging protein (indicated by ‘+1’) between the activator
and the transcription protein. (C) Percentage of proteins interacting with com-
ponents of protein complexes involved in transcription. Only high-throughput
derived protein complex data from the MIPS database were considered.
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ance was emphasized by screens for random activating frag-
ments of the E.coli genome or activating peptides, both of
which mainly identiﬁed acidic activators (56). The ﬁnding
was conﬁrmed in this study by the lower isoelectric point
of activators (Figure 3A), more acidic stretches (Figure 4F)
and by the increased clustering of aspartate (Figure 4E).
Other previously deﬁned activator classes were also mir-
rored by this study: glutamine-rich activators (Figure 4B,
Supplementary Figure 2) (11), proline-rich activators
(Figure 4D) (12) and serine-rich activators (Figure 4C) (57).
Elevated asparagine levels and cluster values (Figure 4A and
Supplementary Figure 2) of activators may indicate a role of
an additional amino acid in transcription activation, possibly
similar to the closely related amino-acid glutamine in
glutamine-rich activators.
It is generally accepted that ADs mediate their function by
speciﬁc interactions with the basal transcription machinery (5)
or additional factors involved in transcription, like chromo-
some remodeling complexes (58). Transcription activators
analyzed in this study form a highly interconnected protein
interaction network involving transcription related proteins
(Figure 5A). Protein interactions with transcription-related
proteins are highly overrepresented, even in the set of activ-
ators which have not been described as TRs (Figure 5B and C).
A signiﬁcant fraction of nuclear Y2H activators as well as
known TRs interact with the basal transcription machinery
(like RNA polymerase II) and chromosome remodeling com-
plexes (like the SAGA complex) (Supplementary Table 4).
These interactions possibly explain their activation properties.
Strikingly, the top ranking interaction partner of nuclear
activators not known to regulate transcription was also
RNA polymerase II. This indicates that genuine transcription
regulators are contained in this set and form the basis for
annotating them as TRs (see Results). However, for a large
fraction of the Y2H activators no interactions are known and
thus their mode of action remains unclear.
A surprising ﬁnding is the frequent interaction of activators
with alcohol dehydrogenase.This enzyme isfoundwith  10%
ofnuclearproteins(datanotshown)butwith  20%inboththe
nuclear activator and known transcription regulator dataset.
Thus, alcohol dehydrogenase might be more a speciﬁc com-
ponent of activation complexes than an unspeciﬁc contamina-
tion. Such moonlighting functions (59) have been found in
other components of various transcription factor complexes
but also among other proteins such as actin which acts both
as a cytoskeletal protein and a transcription factor (60).
Screening of protein fragments fused to the DBD of
Gal4 has been used before to identify transcriptional activat-
ors. Ruden et al. (56) screened fragments of the E.coli genome
and mainly identiﬁed acidic stretches that activate transcrip-
tion in yeast. Wiesner et al. (24) established a screening sys-
tem based on a GFP reporter gene in a murine cell line and
identiﬁed human transcription factors using a cDNA library.
In contrast to this study we could make use of extensive
large-scale studies which not only identiﬁed a set of trans-
cription activators (26,27), but also localized proteins (33),
measured protein concentrations (34) and protein interactions
(26,27,46,47). The measurement of the activation strength let
us focus on sets of proteins highly enriched in known TRs.
Combining several data sources, for six uncharacterized
yeast proteins we could identify additional evidence for
their genuine role in transcriptional regulation.
We are aware that we may have missed a number of activ-
ators: of 138 proteins annotated with the GO-term ‘transcrip-
tional activator activity’ in the YPD database 55 (40%) were
detected as activators in this study (Supplementary Table 1),
suggesting a false negative rate of  60%. This discrepancy
may be explained by the fact that some TRs are annotated
as activators although they do not act as such in our assay.
Other proteins may require speciﬁc promoters, cofactors or
conditions to exhibit activating activity. For example, several
activators are only active when yeast is grown in glucose-
free media. Interestingly, Gal4 itself becomes a very weak
activator when fused to another Gal4–DBD, i.e. the DBD
appears to inhibit the activating properties of some proteins.
Thus, our studies need to be extended in order to get a more
complete picture of all transcriptional activators in yeast, e.g.
by using different conditions or fusing the DBD C-terminally.
Outlook
Although we have identiﬁed a large number of transcriptional
activators in yeast and semi-quantitatively measured their
activation strength, we have not measured activation in a
truly quantitative way. New reporter strains with luciferase
or some other enzyme need to be used in the future for
more precise measurements.
In addition, we have not determined the actual ADs.
Given the poor deﬁnition of ADs, it remains an important
challenge to map these domains by fragmenting the proteins
described here. As ADs do not appear to be well-deﬁned struc-
tural domains it appears to be likely that they do not require
a deﬁned 3D structure. Instead, short linear peptides may con-
tain the activation activity proper.
Once the ADs have been mapped, their interactions with the
transcriptional machinery have to be identiﬁed. Unfortunately,
the classical two-hybrid system cannot be used for this
purpose. Thus either classical biochemistry or alternative sys-
tems have to be used such as the split-Ubiquitin system (61).
Finally, activators can differ in their ability to activate tran-
scription dependent on the promoters to which they are bound
(62,63). Hence all activators need to be tested in different
promoter contexts and their transcriptional activity quantiﬁed.
Once their interactions have been mapped on a proteome-
wide scale and their promoter context evaluated, it may be
possible to generalize these ﬁndings and predict the transcrip-
tional activity of every protein, including their activation
strength. This would be a major step towards quantitative and
thus systems biology.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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